Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 1 day agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 2 days agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 18 hours agoDr. Peter Marks, who oversees the FDA's vaccine division, urged the committee to consider...
F.D.A. Advisers Recommend a New Covid Vaccine Formula for the Fall
New York Times· 2 days agoA committee of advisers to the Food and Drug Administration voted on Wednesday to update the formula...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 17 hours agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 2 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 12 hours agoIf approved, Novavax would finally be able to market its only commercially available product during the fall vaccine season, alongside rivals Pfizer (PFE...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 7 days agoThe company will present preliminary data, highlighting the potential of circulating tumour DNA in the early detection of colorectal cancer. The vaccine...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 2 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...